NYTNYT·2hHealth
score+0.85
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
Original
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
“Framing centers on a significant survival benefit and transformative potential for a severe disease, conveying strong optimism.”